Major IntReALL related literature 


Progress Report on Paeditric Regulation (EC), 2013

La Leucémie de l´enfant en mots et en images


Book list: >> here

    Handbooks/Guides for parents and patients

   Picture/Story books for younger children

   Personal reports by Parents and by Patients




How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012 Oct 4;120(14):2807-16. Epub 2012 Aug 15 doi: 10.1182/blood-2012-02-265884.

Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches. Curr Opin Oncol. 2013 Nov;25(6):707-15. doi: 10.1097/CCO.0000000000000011.

Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia. Hum Mol Genet. 2014 Feb 1;23(3):590-601. doi: 10.1093/hmg/ddt447

Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition. Blood 2014 Nov 27;124(23):3420-30. doi: 10.1182/blood-2014-04-531871

Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group. Haematologica. 2015 Jan; 100(1): e10–e13. doi: 10.3324/haematol.2014.112151 

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react. Br J Haematol.  2015 Apr;169(2):249-61. doi: 10.1111/bjh.13272. Epub 2014 Dec 19.

Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia. Haematologica January 2015. doi:10.3324/haematol.2014.116707

Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment. Leukemia 2015 Aug;29(8):1648-55. Epub 2015 Mar 9 doi:10.1038/leu.2015.59.